| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/03/1993 | EP0530111A1 Indigestible dextrin |
| 03/03/1993 | EP0530087A1 Naphthylethylurea and naphthylethylthiourea compounds, process for their preparation and pharmaceutical compositions containing them |
| 03/03/1993 | EP0530058A1 1,2,4-Thiadiazino(3,4-b)benzothiazole derivatives, their preparation and medicaments containing them |
| 03/03/1993 | EP0529976A1 1,3,2-Dioxathiolan-S-oxide derivatives, their use as fungicedes and as intermediates |
| 03/03/1993 | EP0529898A1 Potentiation of the antitussive effect of dextromethorphan with acetaminophen (paracetamol) |
| 03/03/1993 | EP0529854A2 Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-COA reductase inhibitors |
| 03/03/1993 | EP0529842A2 Production of fluoxetine and new intermediates |
| 03/03/1993 | EP0529749A1 Leukotriene-B4-antagonists, method for their preparation, and their use as medicaments |
| 03/03/1993 | EP0529715A1 Sulfated glycosaminoglycanoid derivatives |
| 03/03/1993 | EP0529702A1 Dihydropyridine derivatives, their preparation and their use |
| 03/03/1993 | EP0529675A2 Shape memory effect surgical needles |
| 03/03/1993 | EP0529654A1 Benzopyran derivatives as potassium channel activators and 5-lipoxygenase inhibitors |
| 03/03/1993 | EP0529636A1 Novel isatinoxime derivatives, their preparation and use |
| 03/03/1993 | EP0529528A2 Novel vitamin D3 analogues |
| 03/03/1993 | EP0529500A1 Medicament for the treatment of rejection reactions during organ transplantations |
| 03/03/1993 | EP0529484A1 Antitussive and expectorant composition |
| 03/03/1993 | EP0529462A1 Benzodioxan derivatives |
| 03/03/1993 | EP0529452A2 1,7-Condensed 2-(piperazinoalkyl)indol derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them |
| 03/03/1993 | EP0529450A1 Substituted mandelic acid derivatives as 5-lipoxygenase inhibitors |
| 03/03/1993 | EP0529410A2 Antibiotic GE 2270 factor C2a |
| 03/03/1993 | EP0529395A2 Benzamide multidrug resistance reversing agents |
| 03/03/1993 | EP0529386A1 Dibenz[B,F][1,4]oxazepin-11(10H)-ones for multidrug resistance reversing agents |
| 03/03/1993 | EP0529253A1 Phenylalkylderivatives, compounds containing them and process for their fabrication |
| 03/03/1993 | EP0529226A1 p-Oxybenzoic acid derivatives, process for preparing them and their use as medicaments |
| 03/03/1993 | EP0529123A1 Pharmaceutical preparation for percutaneous absorption |
| 03/03/1993 | EP0529008A1 Modulation of gene expression through interference with rna secondary structure |
| 03/03/1993 | EP0528985A1 Cephalosporin esters which are useful as antibiotics |
| 03/03/1993 | EP0528978A1 Controlled release dopamine and its use to stimulate nerve fiber growth |
| 03/03/1993 | EP0528975A1 Growth inhibitors and methods of treating cancer and cell proliferative diseases |
| 03/03/1993 | EP0528968A1 (3-alkylthio propyl)-3 benzothiazoline derivatives, preparation thereof and drugs containing said derivatives. |
| 03/03/1993 | EP0528957A1 Five-membered ring alkanoic acid leukotriene antagonists |
| 03/03/1993 | EP0528922A1 New sulfonyl compounds |
| 03/03/1993 | EP0528891A1 Method for increasing blood-brain barrier permeability |
| 03/03/1993 | EP0528862A1 Composition for solid pharmaceutical preparations containing vitamin d 3? derivative and process for preparation thereof |
| 03/03/1993 | EP0512076A4 Method of treating cancer using structured lipids |
| 03/03/1993 | EP0495919A4 Protection from shock subsequent to injury by double-stranded rnas |
| 03/03/1993 | EP0446225B1 Medicament for treatment of pathological vascular permeability and plasma loss to tissue |
| 03/03/1993 | EP0419501B1 Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components |
| 03/03/1993 | EP0394314B1 Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes |
| 03/03/1993 | EP0390930B1 Stable aqueous preparation of active vitamin d 3 |
| 03/03/1993 | EP0321516B1 3-indolepyruvic acid derivatives and pharmaceutical use thereof |
| 03/03/1993 | EP0315698B1 Thieno(triazolo)diazepine compounds and medicinal application of the same |
| 03/03/1993 | EP0310639B1 Omega-3 fatty acids in traumatic injury treatment |
| 03/03/1993 | EP0295300B1 Method and composition for facilitating shaving at the treatment and prevention of pseudofolliculitis barbae |
| 03/03/1993 | EP0165970B1 Hair growth modification |
| 03/03/1993 | EP0153407B1 Injectable physiologically acceptable polymeric compositions |
| 03/03/1993 | CN1069494A 1-methylcarbapenem derivatives, their preparation and their use as antibiotics |
| 03/03/1993 | CN1069492A 4-amidoimidazole derivatives |
| 03/03/1993 | CN1069491A 2-( piperidine-1-yl) ethanol derivatives, process for preparing same and application on therapy |
| 03/03/1993 | CN1069488A HexahydrobenzoÛFÙ quinolinones |
| 03/03/1993 | CN1069485A Process for preparation of succinylcholine halides |
| 03/03/1993 | CN1069484A Phenylalkyl acid derivetives, process for preparing same and process for separating optical isomeride |
| 03/03/1993 | CN1069408A Pharmaceuctical spheroid formulation |
| 03/03/1993 | CN1019978C 11-aryioestrane and 11-arylpregnalle derivatives and preparing method thereof |
| 03/03/1993 | CN1019977C Process for preparing metal complex of N-methyl-11-aza-10-deoxy-10-dihydroerythromycins A and 11-aza-10-deoxy-10-dihydroerythromycins A |
| 03/03/1993 | CN1019974C 1,4-disubstituted-piperidinyl compounds and preparing method thereof |
| 03/03/1993 | CN1019973C Piperidine derivative and pharmaceutical composition containing the same |
| 03/03/1993 | CA2076699A1 Compositions for topical treatment of psoriasis and atopic dermatitis |
| 03/02/1993 | US5191114 Process for enhancing the flow characteristics of ibuprofen |
| 03/02/1993 | US5191093 Process for preparing crystalline calcium pseudomonate |
| 03/02/1993 | US5191092 Antithrombotic iso- and heterocyclic phenylsulphonamides |
| 03/02/1993 | US5191084 Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents |
| 03/02/1993 | US5191072 Lipid a monosaccharide analogues |
| 03/02/1993 | US5190981 Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease |
| 03/02/1993 | US5190978 Carcinostatic compositions and methods |
| 03/02/1993 | US5190977 Antiviral compositions |
| 03/02/1993 | US5190976 Neuroprotective |
| 03/02/1993 | US5190974 N-substituted derivatives of α-mercapto alkylamines, their preparation process and the intermediates obtained, their use as medicaments and the compositions containing them |
| 03/02/1993 | US5190972 Side effect reduction |
| 03/02/1993 | US5190971 Substituted dibenz-oxa-thiocinones, -12-oxides and -12,12-dioxides, a process for their preparation and their use in medicaments |
| 03/02/1993 | US5190970 Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor |
| 03/02/1993 | US5190969 2,3-epoxy derivatives as anti retrovital chemotherapeutic agents |
| 03/02/1993 | US5190967 Medicaments for treating erectile disorders |
| 03/02/1993 | US5190966 Purified hematoporphyrin dimers and trimers useful in photodynamic therapy |
| 03/02/1993 | US5190965 Phenoxyphenyl derivatives, compositions and methods of use thereof |
| 03/02/1993 | US5190962 Treating hypertension |
| 03/02/1993 | US5190961 Thiourea derivatives and antimicrobial agent and antulcer agent containing the same |
| 03/02/1993 | US5190957 Treatment of multi-drug resistant tumors with quinolyl-and isoquinolyloxazole-2-ones |
| 03/02/1993 | US5190954 Methods for the treatment of cognitive disorders |
| 03/02/1993 | US5190948 Use of uridine in the pharmacological treatment of the peripheral complications of diabetes |
| 03/02/1993 | US5190947 Analgesics |
| 03/02/1993 | US5190946 Piperazine compounds restore sensitivity to drug resistant cancer cells |
| 03/02/1993 | US5190941 Use of naphthoxazines for the treatment of conditions associated with cerebral ischaemia |
| 03/02/1993 | US5190939 Antihypoxic |
| 03/02/1993 | US5190938 Elastase inhibitors, treatment of cystic fibrosis, atherosclerosis, rheumatic diseases |
| 03/02/1993 | US5190937 Lactam derivatives |
| 03/02/1993 | US5190936 Process for improving the therapeutic efficacy of fat-soluble corticosteroids and composition for carrying out this process |
| 03/02/1993 | US5190935 Vitamin d analogues |
| 03/02/1993 | US5190925 Use of gangliosides in the treatment of autonomic dysfunction in Chagas' disease |
| 03/02/1993 | US5190924 Peptide amides and amide dimers useful as muscle relaxants |
| 03/02/1993 | US5190876 Method of modifying cellular differentiation and function and compositions therefor |
| 03/02/1993 | US5190765 Latent Drug Delivery |
| 03/02/1993 | US5190763 Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
| 03/02/1993 | US5190758 Sebaceous excitosecretory agent |
| 03/02/1993 | US5190753 3-phenyl-5,6-dihydrobenziciacridine-7-carboxylic acids and related compounds as immunosuppressive agents |
| 03/02/1993 | US5190741 Aminopropyl Radioactive Iodobenzamides |
| 03/02/1993 | US5190589 Compounds and process preparing a substituted or an unsubstituted 4(5)-(ω-aminoalkyl)imidazole |
| 03/02/1993 | CA1314050C Aminotetrahydro-5,6,7,8-naphto(2,3b) furane derivatives, processes for their preparation and pharmaceutical compositions holding same |
| 03/02/1993 | CA1314049C 3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine |
| 03/02/1993 | CA1314048C Quinolinylmethoxyphenylsulfonyl-carboxamides as anti-inflammatory/antiallergic agents |